Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Assets Average (2016 - 2025)

Historic Assets Average for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $170.7 million.

  • Fortress Biotech's Assets Average rose 2512.45% to $170.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $170.7 million, marking a year-over-year increase of 2512.45%. This contributed to the annual value of $155.9 million for FY2024, which is 3249.66% down from last year.
  • Latest data reveals that Fortress Biotech reported Assets Average of $170.7 million as of Q3 2025, which was up 2512.45% from $169.0 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Assets Average ranged from a high of $413.0 million in Q3 2021 and a low of $135.7 million during Q4 2024
  • In the last 5 years, Fortress Biotech's Assets Average had a median value of $222.1 million in 2023 and averaged $260.1 million.
  • Per our database at Business Quant, Fortress Biotech's Assets Average soared by 6270.84% in 2021 and then plummeted by 5181.67% in 2023.
  • Over the past 5 years, Fortress Biotech's Assets Average (Quarter) stood at $402.2 million in 2021, then decreased by 23.18% to $308.9 million in 2022, then tumbled by 48.52% to $159.0 million in 2023, then fell by 14.7% to $135.7 million in 2024, then grew by 25.8% to $170.7 million in 2025.
  • Its Assets Average was $170.7 million in Q3 2025, compared to $169.0 million in Q2 2025 and $161.1 million in Q1 2025.